David Nanchen
About
David Nanchen is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Economics and Econometrics.
According to data from OpenAlex, David Nanchen has authored 110 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Cardiology and Cardiovascular Medicine, 44 papers in Surgery and 20 papers in Economics and Econometrics. Recurrent topics in David Nanchen's work include Lipoproteins and Cardiovascular Health (37 papers), Acute Myocardial Infarction Research (29 papers) and Health Systems, Economic Evaluations, Quality of Life (18 papers). David Nanchen is often cited by papers focused on Lipoproteins and Cardiovascular Health (37 papers), Acute Myocardial Infarction Research (29 papers) and Health Systems, Economic Evaluations, Quality of Life (18 papers). David Nanchen collaborates with scholars based in Switzerland, United Kingdom and Germany. David Nanchen's co-authors include Nicolas Rodondi, Jacques Cornuz, Reto Auer, Jacobijn Gussekloo, Bariş Gencer, François Mach, Douglas C. Bauer, Christian M. Matter, Thomas F. Lüscher and Lorenz Räber and has published in prestigious journals such as JAMA, Circulation and SHILAP Revista de lepidopterología.
In The Last Decade
David Nanchen
92 papers receiving 2.6k citations
Hit Papers
Peers
David Nanchen
Rachel O’Connell Australia
Jeanine E. Roeters van Lennep Netherlands
Genshi Egusa Japan
Eduardo Alegría Spain
G. Ruf Germany
Eva Tuomilehto‐Wolf Finland
Jan Westerink Netherlands
L. Toivanen Finland
Eric J. Stanek United States
Parag H. Joshi United States
Citations per year, relative to David Nanchen David Nanchen (= 1×)
peers
Rachel O’Connell
Countries citing papers authored by David Nanchen
Since
Specialization
Citations
This map shows the geographic impact of David Nanchen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Nanchen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Nanchen more than expected).
Fields of papers citing papers by David Nanchen
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by David Nanchen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Nanchen. The network helps show where David Nanchen may publish in the future.
Co-authorship network of co-authors of David Nanchen
This figure shows the co-authorship network connecting the top 25 collaborators of David Nanchen. A scholar is included among the top collaborators of David Nanchen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Nanchen. David Nanchen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Chamberlain, J. D., Daniel Ackermann, Murielle Bochud, et al.. (2025). Development and validation of an epigenetic signature of allostatic load. Bioscience Reports. 45(4). 247–262.
2.
Branca, Mattia, David Carballo, Konstantinos C. Koskinas, et al.. (2024). Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromes. SHILAP Revista de lepidopterología. 58. 1–8.
3.
Nanchen, David, Lâle Tokgözoğlu, J. Komen, et al.. (2024). Contemporary LDL-cholesterol management in male and female patients at high-cardiovascular risk: results from the European observational SANTORINI study. European Heart Journal. 45(Supplement_1).
4.
Kraler, Simon, Florian A. Wenzl, Bariş Gencer, et al.. (2024). Risk of recurrent ischaemic events in ACS patients with baseline LDL-C below guideline-recommended thresholds: insights from the prospective SPUM-ACS study. European Heart Journal. 45(Supplement_1).
5.
Mahendiran, Thabo, David Nanchen, Stéphane Fournier, et al.. (2024). Anatomy-Informed Multimodal Learning for Myocardial Infarction Prediction. IEEE Open Journal of Engineering in Medicine and Biology. 5. 837–845.
6.
Campbell, David J.T., et al.. (2024). Dépistage et prévention cardiovasculaire mobile dans la population : utile en Suisse ?. Revue Médicale Suisse. 20(864). 466–471.
7.
Rossi, Valentina A., Dik Heg, Sarah Costantino, et al.. (2023). Interleukin-6 plasma levels are elevated in patients with acute myocardial infarction and predict death or recurrent infarction within 1 year - a case-control study. European Heart Journal. 44(Supplement_2).
8.
Vollenweider, Péter, Stéphane Fournier, Olivier Müller, et al.. (2023). Comparison of the European and US guidelines for lipid-lowering therapy in primary prevention of cardiovascular disease. European Journal of Preventive Cardiology. 30(17). 1856–1864.
9.
Ray, Kausik K., Aikaterini Bilitou, Annie Burden, et al.. (2023). Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study. The Lancet Regional Health - Europe. 29. 100624–100624.
10.
Candreva, Alessandro, Barbara E. Stähli, Dik Heg, et al.. (2023). Higher 1‐year mortality on rest days in patients with acute coronary syndromes and decompensated heart failure—A SPUM‐ACS sub‐study. Catheterization and Cardiovascular Interventions. 103(2). 286–294.
11.
Wang, Yidong, Valentina A. Rossi, Dik Heg, et al.. (2023). In patients with acute myocardial infarction interleukin-8 levels are related to impaired renal function and predict recurrent infarction or death at 1-year follow-up - a case-control study. European Heart Journal. 44(Supplement_2).
12.
Eisenring, Christian, Markus F. Oertel, Isabelle Jacot Sadowski, et al.. (2022). Nicotine Replacement Therapy for Smokers with Acute Aneurysmal Subarachnoid Hemorrhage: An International Survey. Advances in Therapy. 39(11). 5244–5258.
13.
Klingenberg, Roland, Soheila Aghlmandi, Lorenz Räber, et al.. (2021). Cysteine‐Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes. Journal of the American Heart Association. 10(20). e020488–e020488.
14.
Ray, Kausik K., Aikaterini Bilitou, Carlos Aguíar, et al.. (2021). Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe – Methodology and rationale for the multinational observational SANTORINI study. SHILAP Revista de lepidopterología. 43. 24–30.
15.
Niederseer, David, Haitham Amin, Lorenz Räber, et al.. (2020). Impact of malignancy on clinical outcomes in patients with acute coronary syndromes. International Journal of Cardiology. 328. 8–13.
16.
Auer, Reto, Bariş Gencer, David Nanchen, et al.. (2016). Uptake and efficacy of a systematic intensive smoking cessation intervention using motivational interviewing for smokers hospitalised for an acute coronary syndrome: a multicentre before–after study with parallel group comparisons. BMJ Open. 6(9). e011520–e011520.
17.
Gencer, Bariş, Reto Auer, David Nanchen, et al.. (2015). Expected impact of applying new 2013 AHA/ACC cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromes. Atherosclerosis. 239(1). 118–124.
18.
Selby, Kevin, David Nanchen, Reto Auer, et al.. (2015). Low statin use in adults hospitalized with acute coronary syndrome. Preventive Medicine. 77. 131–136.
19.
Nanchen, David, David J. Stott, Jacobijn Gussekloo, et al.. (2012). Resting Heart Rate and Incident Heart Failure and Cardiovascular Mortality in Older Adults: Role of Inflammation and Endothelial Dysfunction: The PROSPER Study. European Journal of Heart Failure. 15(5). 581–588.
20.
Gencer, Bariş, Tinh‐Hai Collet, David Bauer, et al.. (2012). SUBCLINICAL THYROID DYSFUNCTION AND THE RISK OF HEART FAILURE EVENTS: AN INDIVIDUAL PARTICIPANT DATA ANALYSIS FROM SIX PROSPECTIVE COHORTS. Journal of General Internal Medicine. 27.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Rachel O’Connell Breakdown of academic impact, for papers by Jeanine E. Roeters van Lennep Breakdown of academic impact, for papers by Genshi Egusa Breakdown of academic impact, for papers by Eduardo Alegría Breakdown of academic impact, for papers by G. Ruf Breakdown of academic impact, for papers by Eva Tuomilehto‐Wolf Breakdown of academic impact, for papers by Jan Westerink Breakdown of academic impact, for papers by L. Toivanen Breakdown of academic impact, for papers by Eric J. Stanek Breakdown of academic impact, for papers by Parag H. Joshi